Kestra Private Wealth Services LLC Purchases 5,110 Shares of Aflac Incorporated (NYSE:AFL)

Kestra Private Wealth Services LLC grew its position in shares of Aflac Incorporated (NYSE:AFL) by 10.5% during the 4th quarter, Holdings Channel reports. The institutional investor owned 53,855 shares of the financial services provider’s stock after buying an additional 5,110 shares during the quarter. Kestra Private Wealth Services LLC’s holdings in Aflac were worth $4,443,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently added to or reduced their stakes in AFL. Flputnam Investment Management Co. raised its position in shares of Aflac by 0.5% during the fourth quarter. Flputnam Investment Management Co. now owns 25,031 shares of the financial services provider’s stock worth $2,065,000 after acquiring an additional 122 shares during the last quarter. Baystate Wealth Management LLC raised its position in shares of Aflac by 24.1% during the third quarter. Baystate Wealth Management LLC now owns 675 shares of the financial services provider’s stock worth $52,000 after acquiring an additional 131 shares during the last quarter. Brighton Jones LLC raised its position in shares of Aflac by 2.3% during the third quarter. Brighton Jones LLC now owns 6,156 shares of the financial services provider’s stock worth $472,000 after acquiring an additional 136 shares during the last quarter. MV Capital Management Inc. raised its position in shares of Aflac by 3.7% during the third quarter. MV Capital Management Inc. now owns 3,779 shares of the financial services provider’s stock worth $290,000 after acquiring an additional 136 shares during the last quarter. Finally, Simon Quick Advisors LLC raised its position in shares of Aflac by 4.9% during the fourth quarter. Simon Quick Advisors LLC now owns 2,950 shares of the financial services provider’s stock worth $243,000 after acquiring an additional 139 shares during the last quarter. Institutional investors own 67.44% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on AFL shares. Piper Sandler raised their price objective on Aflac from $90.00 to $95.00 and gave the stock an “overweight” rating in a research report on Friday, April 5th. UBS Group raised their price objective on Aflac from $80.00 to $84.00 and gave the stock a “neutral” rating in a research report on Wednesday, January 10th. StockNews.com downgraded Aflac from a “hold” rating to a “sell” rating in a report on Wednesday, April 10th. Evercore ISI downgraded Aflac from an “in-line” rating to an “underperform” rating and lifted their target price for the stock from $76.00 to $78.00 in a report on Thursday, January 4th. Finally, Wells Fargo & Company lowered their target price on Aflac from $83.00 to $81.00 and set an “equal weight” rating for the company in a report on Thursday, April 11th. Three investment analysts have rated the stock with a sell rating, eight have issued a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Aflac presently has an average rating of “Hold” and an average price target of $82.15.

Aflac Trading Down 1.1 %

Shares of Aflac stock opened at $83.64 on Wednesday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.06 and a current ratio of 0.06. Aflac Incorporated has a 52 week low of $64.10 and a 52 week high of $86.26. The stock has a 50 day moving average price of $82.89 and a two-hundred day moving average price of $81.84. The stock has a market capitalization of $48.13 billion, a PE ratio of 10.79, a price-to-earnings-growth ratio of 2.29 and a beta of 0.91.

Aflac (NYSE:AFL) last announced its quarterly earnings data on Thursday, February 1st. The financial services provider reported $1.25 EPS for the quarter, missing analysts’ consensus estimates of $1.47 by ($0.22). Aflac had a net margin of 24.92% and a return on equity of 17.59%. The firm had revenue of $3.78 billion during the quarter, compared to analyst estimates of $4.44 billion. During the same period last year, the business posted $1.29 EPS. As a group, equities analysts anticipate that Aflac Incorporated will post 6.41 earnings per share for the current fiscal year.

Insider Buying and Selling at Aflac

In other Aflac news, Director Arthur Reginald Collins sold 3,000 shares of the firm’s stock in a transaction that occurred on Thursday, February 22nd. The stock was sold at an average price of $79.73, for a total value of $239,190.00. Following the completion of the sale, the director now owns 5,592 shares of the company’s stock, valued at $445,850.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, Director Thomas J. Kenny sold 5,000 shares of Aflac stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $84.62, for a total transaction of $423,100.00. Following the transaction, the director now owns 17,920 shares of the company’s stock, valued at $1,516,390.40. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Arthur Reginald Collins sold 3,000 shares of Aflac stock in a transaction that occurred on Thursday, February 22nd. The shares were sold at an average price of $79.73, for a total value of $239,190.00. Following the transaction, the director now directly owns 5,592 shares in the company, valued at approximately $445,850.16. The disclosure for this sale can be found here. Over the last quarter, insiders sold 46,493 shares of company stock valued at $3,765,706. Company insiders own 0.80% of the company’s stock.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.